| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1915983 | Journal of the Neurological Sciences | 2008 | 4 Pages |
Abstract
Withdrawal of penicillamine from zinc sulphate/penicillamine maintenance therapy for patients with Wilson's disease was effective, safe and economic, for almost all patients. This retrospective study reiterates that zinc sulphate may be used as a preferred mode of treatment for patients with Wilson's disease.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
S. Sinha, A.B. Taly,